116 related articles for article (PubMed ID: 2122645)
1. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-like compounds on mitochondrial respiration.
Suzuki K; Mizuno Y; Yoshida M
Adv Neurol; 1990; 53():215-8. PubMed ID: 2122645
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of mitochondrial respiration by 1,2,3,4-tetrahydroisoquinoline-like endogenous alkaloids in mouse brain.
Suzuki K; Mizuno Y; Yoshida M
Neurochem Res; 1990 Jul; 15(7):705-10. PubMed ID: 1975653
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of mitochondrial NADH-ubiquinone oxidoreductase activity and ATP synthesis by tetrahydroisoquinoline.
Suzuki K; Mizuno Y; Yoshida M
Neurosci Lett; 1988 Mar; 86(1):105-8. PubMed ID: 3129681
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of complex I by N-methylisoquinolinium ion and N-methyl-1,2,3,4-tetrahydroisoquinoline in isolated mitochondria prepared from mouse brain.
Suzuki K; Mizuno Y; Yamauchi Y; Nagatsu T; Mitsuo Y
J Neurol Sci; 1992 Jun; 109(2):219-23. PubMed ID: 1353109
[TBL] [Abstract][Full Text] [Related]
5. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on activities of the enzymes in the electron transport system in mouse brain.
Mizuno Y; Sone N; Saitoh T
J Neurochem; 1987 Jun; 48(6):1787-93. PubMed ID: 3106573
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of mitochondrial respiration by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse brain in vivo.
Mizuno Y; Suzuki K; Sone N; Saitoh T
Neurosci Lett; 1988 Sep; 91(3):349-53. PubMed ID: 3141846
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
McNaught KS; Thull U; Carrupt PA; Altomare C; Cellamare S; Carotti A; Testa B; Jenner P; Marsden CD
Biochem Pharmacol; 1995 Nov; 50(11):1903-11. PubMed ID: 8615871
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of ATP synthesis by 1-methyl-4-phenylpyridinium ion (MPP+) in mouse brain in vitro and in vivo.
Mizuno Y; Suzuki K; Sone N
Adv Neurol; 1990; 53():197-200. PubMed ID: 2122644
[TBL] [Abstract][Full Text] [Related]
9. [Contribution of MPTP to studies on the pathogenesis of Parkinson's disease].
Mizuno Y
Rinsho Shinkeigaku; 1989 Dec; 29(12):1494-6. PubMed ID: 2698296
[TBL] [Abstract][Full Text] [Related]
10. 1-Methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (salsolinol) is toxic to dopaminergic neuroblastoma SH-SY5Y cells via impairment of cellular energy metabolism.
Storch A; Kaftan A; Burkhardt K; Schwarz J
Brain Res; 2000 Feb; 855(1):67-75. PubMed ID: 10650131
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of alpha-ketoglutarate dehydrogenase by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
McNaught KS; Altomare C; Cellamare S; Carotti A; Thull U; Carrupt PA; Testa B; Jenner P; Marsden CD
Neuroreport; 1995 May; 6(8):1105-8. PubMed ID: 7662887
[TBL] [Abstract][Full Text] [Related]
12. 1-Methyl-1,2,3,4-tetrahydroisoquinoline, decreasing in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse, prevents parkinsonism-like behavior abnormalities.
Tasaki Y; Makino Y; Ohta S; Hirobe M
J Neurochem; 1991 Dec; 57(6):1940-3. PubMed ID: 1940911
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial and metabolic toxicity of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine.
Kindt MV; Heikkila RE; Nicklas WJ
J Pharmacol Exp Ther; 1987 Sep; 242(3):858-63. PubMed ID: 3498818
[TBL] [Abstract][Full Text] [Related]
14. Effects of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on mitochondrial respiration.
McNaught KS; Thull U; Carrupt PA; Altomare C; Cellamare S; Carotti A; Testa B; Jenner P; Marsden CD
Biochem Pharmacol; 1996 Jun; 51(11):1503-11. PubMed ID: 8630091
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of mitochondrial NADH-ubiquinone oxidoreductase activity by 1-methyl-4-phenylpyridinium ion.
Mizuno Y; Saitoh T; Sone N
Biochem Biophys Res Commun; 1987 Feb; 143(1):294-9. PubMed ID: 3103619
[TBL] [Abstract][Full Text] [Related]
16. Preventative effects of 1-methyl-1,2,3,4-tetrahydroisoquinoline derivatives (
Munakata H; Ishikawa R; Saitoh T; Kambe T; Chiba T; Taguchi K; Abe K
Can J Physiol Pharmacol; 2022 Jul; 100(7):594-611. PubMed ID: 35413210
[TBL] [Abstract][Full Text] [Related]
17. Selective dopaminergic neurotoxicity of isoquinoline derivatives related to Parkinson's disease: studies using heterologous expression systems of the dopamine transporter.
Storch A; Ott S; Hwang YI; Ortmann R; Hein A; Frenzel S; Matsubara K; Ohta S; Wolf HU; Schwarz J
Biochem Pharmacol; 2002 Mar; 63(5):909-20. PubMed ID: 11911843
[TBL] [Abstract][Full Text] [Related]
18. Studies on the toxicity of 1-methyl-4-phenylpyridinium ion (MPP+) against mitochondria of mouse brain.
Mizuno Y; Sone N; Suzuki K; Saitoh T
J Neurol Sci; 1988 Aug; 86(1):97-110. PubMed ID: 3262717
[TBL] [Abstract][Full Text] [Related]
19. [The search for endogenous or exogenous MPTP-like substances].
Nagatsu T
Rinsho Shinkeigaku; 1989 Dec; 29(12):1497-500. PubMed ID: 2517047
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial factors involved in Parkinson's disease by MPTP toxicity in Macaca fascicularis and drug effect.
Villa RF; Arnaboldi R; Ghigini B; Gorini A
Neurochem Res; 1992 Nov; 17(11):1147-54. PubMed ID: 1461362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
